TriSalus Life Sciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $11,213 | $9,167 | $8,261 | $7,349 |
Gross Profit | 9,411 | 7,672 | 7,045 | 6,345 |
EBITDA | -6,703 | -8,989 | -1,091 | |
EBIT | -6,868 | -9,161 | -7,580 | -1,260 |
Net Income | -8,288 | -10,375 | -10,108 | -2,399 |
Net Change In Cash | 11,213 | 9,167 | 8,261 | 7,349 |
Free Cash Flow | -7,227 | -5,253 | -5,757 | -11,016 |
Cash | 26,490 | 13,000 | 8,525 | 11,288 |
Basic Shares | 32,899 | 28,527 | 31,279 | 26,501 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $29,431 | $18,511 | $12,398 | $8,401 |
Gross Profit | 25,328 | 15,906 | 10,140 | 7,208 |
EBITDA | -36,165 | -58,298 | -46,763 | -23,568 |
EBIT | -33,129 | -59,000 | -47,177 | -24,032 |
Net Income | -33,233 | -59,038 | -47,187 | -28,845 |
Net Change In Cash | 29,431 | 18,511 | 12,398 | 8,401 |
Free Cash Flow | -41,188 | -51,166 | -33,099 | -23,955 |
Cash | 8,525 | 11,777 | 9,414 | 30,301 |
Basic Shares | 26,501 | 26,465 | 29,608 | 31,250 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.27 |
2025-03-31 | -$0.40 |
2024-12-31 | -$0.40 |
2024-09-30 | -$0.39 |
